The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantum mechanics–based multi-tensor AI/ML discovery and validation of actionable and mechanistically interpretable whole-transcriptome predictors of survival in response to immunotherapy from real-world clinical trial data.
 
Orly Alter
Leadership - Prism AI Therapeutics, Inc.; https://prism-ai.com
Stock and Other Ownership Interests - Prism AI Therapeutics, Inc.; https://prism-ai.com
Consulting or Advisory Role - Prism Al Therapeutics, Inc.; https://prism-ai.com
Patents, Royalties, Other Intellectual Property - 1. O. Alter, “Genetic Alterations in Glioblastoma,” European Patent EP 2773777 A4 (May 2020); https://patents.google.com/patent/EP2773777A4; 2. O. Alter, “Genetic Alterations in Glioma,” United States Patent US 10202643 B2 (February 2019); https://patents.google.com/patent/US10202643B2
 
David Oberman
Employment - Prism Al Therapeutics, Inc.; https://prism-ai.com
Leadership - Prism Al Therapeutics, Inc.; https://prism-ai.com
Stock and Other Ownership Interests - Prism Al Therapeutics, Inc.; https://prism-ai.com
Patents, Royalties, Other Intellectual Property - 1. O. Alter, "Genetic Alterations in Glioblastoma," European Patent EP 2773777 A4 (May 2020); https://patents.google.com/ patent/EP2773777A4 (I); O. Alter, "Genetic Alterations in Glioma," United States Patent US 10202643 B2 (February 2019); https:// patents.google.com/patent/US10202643B2 (I)
 
Asaf Zviran
Employment - Prism Al Therapeutics, Inc.; https://prism-ai.com
Leadership - Prism Al Therapeutics, Inc.; https://prism-ai.com
Stock and Other Ownership Interests - Prism Al Therapeutics, Inc.; https://prism-ai.com